Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis
Status:
Completed
Trial end date:
2014-09-30
Target enrollment:
Participant gender:
Summary
Evaluate the disease activity guided tapering and discontinuation strategies of etanercept
(ETN) in patients with ankylosing spondylitis (AS) in 48 weeks.
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
First Affiliated Hospital of Wenzhou Medical University Ningbo Medical Center Lihuili Hospital Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shaoxing People's Hospital Shaoxing Second Hospital The First Hospital of Jiaxing Wenzhou Central Hospital Zhejiang Provincial People's Hospital Zhejiang Provincial People’s Hospital